Previous Article | Next Article 
Journal of Virology, April 1999, p. 2667-2674, Vol. 73, No. 4
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Vif and the p55Gag Polyprotein of Human
Immunodeficiency Virus Type 1 Are Present in Colocalizing Membrane-Free
Cytoplasmic Complexes
James H. M.
Simon,1
Elise A.
Carpenter,2
Ron A. M.
Fouchier,2 and
Michael H.
Malim1,2,3,*
Howard Hughes Medical
Institute2 and Departments of
Microbiology1 and
Medicine,3 University of Pennsylvania
School of Medicine, Philadelphia, Pennsylvania 19104-6148
Received 30 July 1998/Accepted 9 December 1998
The Vif protein of human immunodeficiency virus type 1 (HIV-1) is a
potent regulator of viral infectivity. Current data posit that Vif
functions late in replication to modulate assembly, budding, and/or
maturation. Consistent with this model, earlier indirect immunofluorescence analyses of HIV-1-infected cells demonstrated that
Vif and Gag colocalize to a substantial degree (J. H. M. Simon, R. A. M. Fouchier, T. E. Southerling, C. B. Guerra, C. K. Grant, and M. H. Malim, J. Virol.
71:5259-5267, 1997). Here, we describe a series of subcellular
fractionation studies which indicate that Vif and the
p55Gag polyprotein are present in membrane-free cytoplasmic
complexes that copurify in sucrose density gradients and are stable in
nonionic detergents. Both Vif and Gag are targeted to these complexes
independent of each other, and their association with them appears to
be mediated by protein-protein interactions. We propose that these
complexes may represent viral assembly intermediates and that Vif is
appropriately localized to influence the final stages of the viral life
cycle and, therefore, the infectivity of progeny virions.
*
Corresponding author. Mailing address: Departments of
Microbiology and Medicine, University of Pennsylvania School of
Medicine, Clinical Research Bldg., Room 347B, 415 Curie Blvd.,
Philadelphia, PA 19104-6148. Phone: (215) 573-3493. Fax: (215)
573-2172. E-mail: malim{at}mail.med.upenn.edu.
Journal of Virology, April 1999, p. 2667-2674, Vol. 73, No. 4
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Henriet, S., Mercenne, G., Bernacchi, S., Paillart, J.-C., Marquet, R.
(2009). Tumultuous Relationship between the Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) and the Human APOBEC-3G and APOBEC-3F Restriction Factors. Microbiol. Mol. Biol. Rev.
73: 211-232
[Abstract]
[Full Text]
-
Blay, W. M., Kasprzyk, T., Misher, L., Richardson, B. A., Haigwood, N. L.
(2007). Mutations in Envelope gp120 Can Impact Proteolytic Processing of the gp160 Precursor and Thereby Affect Neutralization Sensitivity of Human Immunodeficiency Virus Type 1 Pseudoviruses. J. Virol.
81: 13037-13049
[Abstract]
[Full Text]
-
Bernacchi, S., Henriet, S., Dumas, P., Paillart, J.-C., Marquet, R.
(2007). RNA and DNA Binding Properties of HIV-1 Vif Protein: A FLUORESCENCE STUDY. J. Biol. Chem.
282: 26361-26368
[Abstract]
[Full Text]
-
Jager, S., Gottwein, E., Krausslich, H.-G.
(2007). Ubiquitination of Human Immunodeficiency Virus Type 1 Gag Is Highly Dependent on Gag Membrane Association. J. Virol.
81: 9193-9201
[Abstract]
[Full Text]
-
Henriet, S., Sinck, L., Bec, G., Gorelick, R. J., Marquet, R., Paillart, J.-C.
(2007). Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription. Nucleic Acids Res
35: 5141-5153
[Abstract]
[Full Text]
-
Scheifele, L. Z., Ryan, E. P., Parent, L. J.
(2005). Detailed Mapping of the Nuclear Export Signal in the Rous Sarcoma Virus Gag Protein. J. Virol.
79: 8732-8741
[Abstract]
[Full Text]
-
Ribeiro, A. C., Maia e Silva, A., Santa-Marta, M., Pombo, A., Moniz-Pereira, J., Goncalves, J., Barahona, I.
(2005). Functional Analysis of Vif Protein Shows Less Restriction of Human Immunodeficiency Virus Type 2 by APOBEC3G. J. Virol.
79: 823-833
[Abstract]
[Full Text]
-
Luo, K., Liu, B., Xiao, Z., Yu, Y., Yu, X., Gorelick, R., Yu, X.-F.
(2004). Amino-Terminal Region of the Human Immunodeficiency Virus Type 1 Nucleocapsid Is Required for Human APOBEC3G Packaging. J. Virol.
78: 11841-11852
[Abstract]
[Full Text]
-
Bennett, E. M., Lever, A. M. L., Allen, J. F.
(2004). Human Immunodeficiency Virus Type 2 Gag Interacts Specifically with PRP4, a Serine-Threonine Kinase, and Inhibits Phosphorylation of Splicing Factor SF2. J. Virol.
78: 11303-11312
[Abstract]
[Full Text]
-
Feng, F., Davis, A., Lake, J.-A., Carr, J., Xia, W., Burrell, C., Li, P.
(2004). Ring Finger Protein ZIN Interacts with Human Immunodeficiency Virus Type 1 Vif. J. Virol.
78: 10574-10581
[Abstract]
[Full Text]
-
Cen, S., Guo, F., Niu, M., Saadatmand, J., Deflassieux, J., Kleiman, L.
(2004). The Interaction between HIV-1 Gag and APOBEC3G. J. Biol. Chem.
279: 33177-33184
[Abstract]
[Full Text]
-
Halwani, R., Cen, S., Javanbakht, H., Saadatmand, J., Kim, S., Shiba, K., Kleiman, L.
(2004). Cellular Distribution of Lysyl-tRNA Synthetase and Its Interaction with Gag during Human Immunodeficiency Virus Type 1 Assembly. J. Virol.
78: 7553-7564
[Abstract]
[Full Text]
-
Dooher, J. E., Lingappa, J. R.
(2004). Conservation of a Stepwise, Energy-Sensitive Pathway Involving HP68 for Assembly of Primate Lentivirus Capsids in Cells. J. Virol.
78: 1645-1656
[Abstract]
[Full Text]
-
Liu, B., Yu, X., Luo, K., Yu, Y., Yu, X.-F.
(2004). Influence of Primate Lentiviral Vif and Proteasome Inhibitors on Human Immunodeficiency Virus Type 1 Virion Packaging of APOBEC3G. J. Virol.
78: 2072-2081
[Abstract]
[Full Text]
-
Gaddis, N. C., Chertova, E., Sheehy, A. M., Henderson, L. E., Malim, M. H.
(2003). Comprehensive Investigation of the Molecular Defect in vif-Deficient Human Immunodeficiency Virus Type 1 Virions. J. Virol.
77: 5810-5820
[Abstract]
[Full Text]
-
Halwani, R., Khorchid, A., Cen, S., Kleiman, L.
(2003). Rapid Localization of Gag/GagPol Complexes to Detergent-Resistant Membrane during the Assembly of Human Immunodeficiency Virus Type 1. J. Virol.
77: 3973-3984
[Abstract]
[Full Text]
-
Kao, S., Akari, H., Khan, M. A., Dettenhofer, M., Yu, X.-F., Strebel, K.
(2002). Human Immunodeficiency Virus Type 1 Vif Is Efficiently Packaged into Virions during Productive but Not Chronic Infection. J. Virol.
77: 1131-1140
[Abstract]
[Full Text]
-
Madani, N., Millette, R., Platt, E. J., Marin, M., Kozak, S. L., Bloch, D. B., Kabat, D.
(2002). Implication of the Lymphocyte-Specific Nuclear Body Protein Sp140 in an Innate Response to Human Immunodeficiency Virus Type 1. J. Virol.
76: 11133-11138
[Abstract]
[Full Text]
-
Goncalves, J., Silva, F., Freitas-Vieira, A., Santa-Marta, M., Malho, R., Yang, X., Gabuzda, D., Barbas, C. III
(2002). Functional Neutralization of HIV-1 Vif Protein by Intracellular Immunization Inhibits Reverse Transcription and Viral Replication. J. Biol. Chem.
277: 32036-32045
[Abstract]
[Full Text]
-
Khorchid, A., Halwani, R., Wainberg, M. A., Kleiman, L.
(2002). Role of RNA in Facilitating Gag/Gag-Pol Interaction. J. Virol.
76: 4131-4137
[Abstract]
[Full Text]
-
Bardy, M., Gay, B., Pebernard, S., Chazal, N., Courcoul, M., Vigne, R., Decroly, E., Boulanger, P.
(2001). Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing. J. Gen. Virol.
82: 2719-2733
[Abstract]
[Full Text]
-
Mouland, A. J., Xu, H., Cui, H., Krueger, W., Munro, T. P., Prasol, M., Mercier, J., Rekosh, D., Smith, R., Barbarese, E., Cohen, E. A., Carson, J. H.
(2001). RNA Trafficking Signals in Human Immunodeficiency Virus Type 1. Mol. Cell. Biol.
21: 2133-2143
[Abstract]
[Full Text]
-
Henzler, T., Harmache, A., Herrmann, H., Spring, H., Suzan, M., Audoly, G., Panek, T., Bosch, V.
(2001). Fully functional, naturally occurring and C-terminally truncated variant human immunodeficiency virus (HIV) Vif does not bind to HIV Gag but influences intermediate filament structure. J. Gen. Virol.
82: 561-573
[Abstract]
[Full Text]
-
Öhagen, A., Gabuzda, D.
(2000). Role of Vif in Stability of the Human Immunodeficiency Virus Type 1 Core. J. Virol.
74: 11055-11066
[Abstract]
[Full Text]
-
Rousso, I., Mixon, M. B., Chen, B. K., Kim, P. S.
(2000). Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity. Proc. Natl. Acad. Sci. USA
10.1073/pnas.240459697v1
[Abstract]
[Full Text]
-
Dettenhofer, M., Cen, S., Carlson, B. A., Kleiman, L., Yu, X.-F.
(2000). Association of Human Immunodeficiency Virus Type 1 Vif with RNA and Its Role in Reverse Transcription. J. Virol.
74: 8938-8945
[Abstract]
[Full Text]
-
Zhang, H., Pomerantz, R. J., Dornadula, G., Sun, Y.
(2000). Human Immunodeficiency Virus Type 1 Vif Protein Is an Integral Component of an mRNP Complex of Viral RNA and Could Be Involved in the Viral RNA Folding and Packaging Process. J. Virol.
74: 8252-8261
[Abstract]
[Full Text]
-
Tritel, M., Resh, M. D.
(2000). Kinetic Analysis of Human Immunodeficiency Virus Type 1 Assembly Reveals the Presence of Sequential Intermediates. J. Virol.
74: 5845-5855
[Abstract]
[Full Text]
-
Simon, J. H. M., Sheehy, A. M., Carpenter, E. A., Fouchier, R. A. M., Malim, M. H.
(1999). Mutational Analysis of the Human Immunodeficiency Virus Type 1 Vif Protein. J. Virol.
73: 2675-2681
[Abstract]
[Full Text]
-
Yang, S., Sun, Y., Zhang, H.
(2001). The Multimerization of Human Immunodeficiency Virus Type I Vif Protein. A REQUIREMENT FOR Vif FUNCTION IN THE VIRAL LIFE CYCLE. J. Biol. Chem.
276: 4889-4893
[Abstract]
[Full Text]
-
Rousso, I., Mixon, M. B., Chen, B. K., Kim, P. S.
(2000). Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity. Proc. Natl. Acad. Sci. USA
97: 13523-13525
[Abstract]
[Full Text]